References
- Siegler RL. Spectrum of extrarenal involvement in postdiar-rheal hemolytic-uremic syndrome. J Pediatr. 1994;125:511–8.
- Shiomi M, Togawa M, Fujita K, Murata R. Effect of early oral fluoroquinolones in hemorrhagic colitis due to Escherichia coli 0157:H7. Pediatr Int. 1999;41:228–32.
- Ikeda K, Ida O, Kimoto K, Takatorige T, Nakanishi N, Tatara K. Effect of early fosfomycin treatment on prevention of hemolytic uremic syndrome accompanying Escherichia coli 0157:H7 infection. Chin Nephrol. 1999;52:357–62.
- Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI. The risk of the hemolytic-uremic syndrome after antibiotic treat-ment of Escherichia coli 0157:H7 infections. N Engl J Med. 2000;342: 1930–6.
- Grif K, Dierich MP, Karch H, Allerberger F. Strain-specific differences in the amount of shiga toxin released from enterohemorrhagic Escherichia coil 0157 following exposure to subinhibitory concentrations of antimicrobial agents. Eur J Clin Microbiol Infect Dis. 1998;17:761–6.
- Zhang X, McDaniel AD, Wolf LE, Keusch GT, Waldor MK, Acheson DWK. Quin°lone antibiotics induce shiga toxin-encoding bacteriophages, toxin production, and death in mice. J Infect Dis. 2000;181:664–70.
- Donskey CJ, Hume ME, Callaway TR, Das SM, Hoyen CK, Rice LB. Inhibition of vancomycin-resistant enterococci by an in vitro continuous-flow competitive exclusion culture con-taining human stool flora. J Infect Dis. 2001;184:1624–7.
- Freter R. Experimental enteric Shigella and Vibrio infections in mice and guinea pigs. J Exp Med. 1956;104:411–8.
- Hentges DJ, Stein AJ, Casey SW, Que JU. Protective role of intestinal flora against infection with Pseudomonas aeruginosa in mice: influence of antibiotics on colonization resistance. Infect Immun. 1985;47:118–22.
- Kennedy MJ, Volz PA. Ecology of Candida albicans gut colonization: inhibition of Candida adhesion, colonization, and dissemination from the gastrointestinal tract by bacterial antagonism. Infect Immun. 1985;49:654–63.
- Que JU, Casey SW, Hentges DJ. Factors responsible for increased susceptibility of mice to intestinal colonization after treatment with streptomycin. Infect Immun. 1986;53:116–23.
- Freter R. Gnotobiotic and germfree animal systems. In: Poindexter JS, Leadbetter ER. editors. Bacteria in Nature, Vol. 2. New York: Plenum; 1986. p. 205–27.
- Hirayama K. Ex-germfree mice harboring intestinal micro-biota derived from other animal species as an experimental model for ecology and metabolism of intestinal bacteria. Exp Anim. 1999;48:219–27.
- Hentges DJ, Marsh WW, Petschow BW, Thal WR, Carter MK. Influence of infant diets on the ecology of the intestinal tract of human flora-associated mice. J Pediatr Gastroenterol Nutr. 1992;14:146–52.
- Narushima S, Itoh K, Mitsuoka T, Nakayama H, Itoh T, Hioki K, et al. Effect of mouse intestinal bacteria on incidence of colorectal tumors induced by 1,2-dimethylhydrazine injec-tion in gnotobiotic transgenic mice harboring human proto-type c-Ha-ras genes. Exp Anim. 1998;47:111–7.
- Mitsuoka T, Ohno K, Benno Y, Suzuki K, Namba K. Die Faekalflora bei Menschen. IV. Mitteilung: Vergleich des neu entwickelten Verfahrens mit dem bisherigen iiblichen Verfah- ren zur Darmflora analyse, Zentralbl Bakt Hyg I Abt Orig, 1976;A234:219–33.
- Benno Y, Endo K, Mizutani T, Namba Y, Komori T, Mitsuoka T. Comparison of fecal microflora of elderly persons in rural and urban areas of Japan. Appl Environ Microbiol. 1989;55:1100–5.
- Mitsuoka T. Vergleichende Untersuchungen fiber die Bifido-bakterien aus dem Verdauungstrakt von Menschen und Tieren (Zugleich die Beschreibung von B. thermophilum nov. spec. und B. pseudolongum nov. spec.). Zentralbl Bakt Parasit Infekt Hyg I Abt Orig. 1969;210:52–64.
- Hoogkamp-korstanje JAA, Lindner JGEM, Marcelis JH, den Daas-Slagt H, de Vos NM. Composition and ecology of the human intestinal flora. Antonie van Leeuwenhoek. 1979; 45:35–40.
- Benno Y, Sawada K, Mitsuoka T. The intestinal microflora of infants: composition of fecal flora in breast-fed and bottle-fed infants. Microbiol Immunol. 1984;28:975–86.
- Miyamoto Y, Watanabe K, Tanaka R, Itoh K. Distribution analysis of six predominant Bacteroides species in normal human feces using 16S rDNA-targeted species-specific pri-mers. Microb Ecol Health Dis. 2002;14:133–6.
- Matsuki T, Watanabe K, Tanaka R, Fukuda M, Oyaizu H. Distribution of bifidobacterial species in human intestinal microflora examined with 16S rRNA-gene-targeted species-specific primers. Appl Environ Microbiol. 1999;65: 4506–12.
- He F, Ouwehand AC, Isolauri E, Hashimoto H, Benno Y, Salminen S. Comparison of mucosal adhesion and species identification of bifidobacteria isolated from healthy and allergic infants. FEMS Immunol Med Microbiol. 2001; 30:43–7.
- Ouwehand AC, Isolauri E, He F, Hashimoto H, Benno Y, Salminen S. Differences in Bifidobacterium flora composition in allergic and healthy infants. J Allergy Chin Immunol. 2001;108:144–5.
- Hentges DJ. The protective function of the indigenous intestinal flora. Pediatr Infect Dis. 1986;5:517–20.
- Savage DC. Factors influencing biocontrol of bacterial pathogens in the intestine. Food Tech. 1987;41:82–7.
- Mitsuoka T, Sega T, Yamamoto S. Eine verbesserte Methodik der qualitativen und quantitativen Analyse der Darmflora von Menschen und Tieren. Zentralbl Bakt Parasit Infekt Hyg I Orig. 1965;195:455–69.